Skip to main content
Medical Affairs Consulting · Latin AmericaMedical consulting · Pharma, biotech and health technology

Thirty years of medical leadership, available by the project.

I provide specialized Medical Affairs and medical leadership services to pharmaceutical, biotech, medical device and health technology companies operating or expanding in Latin America. Thirty years inside the industry, not observing it from outside.

Fractional Chief Medical Officer · Interim medical direction · Project-based consulting

Book a 30-minute call
Black and white portrait of Dr. Byron Monzón López

Track record

Three decades of measurable results across Latin America.

30+

years of leadership

6

pharmaceutical companies

100+

medical projects

25+

product launches

100+

key opinion leaders

3,000+

medical materials

Career spanning Mexico, Central America, South America and the Caribbean.

Some of the companies where I have worked

Six companies

NovartisMerckProcter & GambleRoemmersLaboratorios PanalabRowe
  • Novartis
  • Merck
  • Procter & Gamble
  • Roemmers
  • Panalab
  • Rowe

Medical training methodologies and regional projects developed for these organizations.

Distinctions

Judgement that institutions have already backed.

2

Recognition

Two International Awards for Medical Excellence, for contributions to Medical Affairs at Merck and Roemmers Central America.

5

Editorial

Editor of five scientific journals and specialized websites.

LATAM

Clinical research

Introduced Novartis global clinical research to Latin America.

Credentials

  • Licensed physician, Colegio de Médicos de Guatemala
  • Master's degree in Diabetes and Metabolic Syndrome, Universidad Francisco Marroquín
  • Internship and residency, Universidad de San Carlos and Hospital Roosevelt
  • Training in Regulatory Affairs, Marketing and Pharmacovigilance
  • Certified trainer
  • Bilingual Spanish and English

The problem

Medical capability is almost never brought in on time.

Some arrive in Latin America with a global medical strategy that does not survive contact with the region. Others prepare a launch with no medical department. Others have had the position open for months and the calendar will not wait.

The cost of waiting is not the hire that never happened. It is the launch with no scientific narrative, the commercial team that cannot hold a conversation with a specialist, the Advisory Board convened too late, and the material that went out carrying a claim the evidence does not support.

None of the three is solved by an external report. They are solved by someone who takes the medical judgement, signs it and answers for it, for as long as it takes and not a month longer.

The fractional model covers the interval between “we need medical capability now” and “we can justify a permanent executive position”.

The calendar does not wait for the medical department.

Services

Six lines of work.

LeadershipFractional Chief Medical Officer and interim medical directionExternal medical leadership for companies that need a medical head without hiring a permanent executive position yet. I join as an extension of the team to develop medical strategy, coordinate regional projects and connect Medical, Commercial, Regulatory, Market Access and Pharmacovigilance.Client value:immediate access to executive-level medical judgement, with the flexibility of a project-based or hourly contract.ContentMedical writing, medical review and MLRDevelopment and review of medical, scientific and promotional materials so they are accurate, clear, balanced and consistent with the evidence, including serving as medical reviewer in MLR processes. I have developed and reviewed more than 3,000 materials.Client value:fewer scientific errors and less reputational risk, faster approvals and more credible communication.EngagementKOL mapping, Advisory Boards and scientific engagementIdentification, classification and development of relationships with key opinion leaders, investigators, medical societies and institutions by therapeutic area, plus planning and chairing of Advisory Boards. More than 100 KOLs and more than 50 conferences.Client value:resources concentrated on the experts who add the most knowledge and credibility.StrategyMedical strategy and launch readinessMedical strategies for medicines, devices and health solutions before, during and after launch. More than 25 launches and strategic medical guidance for more than 20 new products.Client value:greater organizational readiness, stronger scientific differentiation and less improvisation.TrainingMSL and commercial team trainingPrograms for representatives, MSLs, product managers, access teams and distributors. Methodologies established for more than 500 medical representatives and more than 500 sales and management teams, across more than 15 companies.Client value:teams able to communicate the evidence clearly, ethically and convincingly.IntelligenceMedical intelligence and evidence strategyAnalysis of publications, clinical studies, guidelines, competitors and trends to turn complex information into practical recommendations.Client value:better grounded decisions and the ability to anticipate market moves.

Engagement models

Five ways to engage. They combine.

ModelWho it fitsWhat it includesCommitment
Hourly consultingTeams with one concrete medical questionAdvisory sessions and one-off reviewHourly, no minimum
Defined projectCompanies with a dated deliverableFixed scope, deliverables and timeline4 to 12 weeks
Launch supportNew products entering the regionMedical readiness before, during and afterTied to the launch calendar
Monthly retainerOperations needing continuous medical judgementAllocated monthly hours and a fixed cadenceQuarterly minimum
Fractional Chief Medical OfficerCompanies with no medical department or a vacant positionPart-time medical direction and external representation6 to 12 months

The model is decided in the first conversation, not before it. Scope agreed in writing before work starts. Fees on request.

I turn down more work than I take on.

Yes, if...

  • You are entering Latin America and do not have a medical department yet
  • You are preparing a product launch in the region
  • The medical position is vacant and you need it covered while you hire
  • You are a small or mid-size pharmaceutical company, a biotech or a regional distributor
  • You need senior medical judgement without opening a permanent role

Probably not, if...

  • You are looking for volume staffing rather than medical leadership
  • You need full-time daily operational execution in a single country
  • You expect results without defined scope, objectives or indicators
  • You need medical judgement to back a claim the evidence does not support

Speaking

Beyond the prescription

A talk about what happens when the evidence leaves the exam room and enters the clinical decision.

Active clinical practice

The medical strategy I recommend, I hold up in clinic.

I still see patients. That is why the medical strategy, materials and training I develop hold up in real practice and not only in the literature. A consultant who left the exam room fifteen years ago advises from memory; I advise from last week.

DiabetCentro, Guatemala City
7a avenida 9-64 zona 9, Edificio Zona Médica, fifth floor, office 515
Monday to Friday, 07:00 to 16:00

See the clinical profile at DiabetCentro

Medical Affairs expertise that transforms scientific evidence into strategies, capabilities and business results across Latin America.

Share this profileSend by email